Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.

American journal of respiratory and critical care medicine·2026

Same author

Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).

JAMA oncology·2026

Same author

[Lung transplantation, a contemporary review for the general parctitioner].

MMW Fortschritte der Medizin·2026

Same author

[Comparative analysis of drug therapy for fibrotic interstitial lung diseases based on results of phase 3 trials].

Pneumologie (Stuttgart, Germany)·2026

Same author

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

NPJ precision oncology·2026

Same author

Benchmarking DNA barcode decoding strategies under high error rates.

BMC bioinformatics·2026

Search research articles

Related Experiment Video

Updated: Jul 10, 2025

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung

Kathrin Kahnert^1,2, Lilli Maria Lempert¹, Jürgen Behr^1,2

¹Department of Medicine V, University Hospital, LMU Munich, Munich, Germany.

Therapeutic Advances in Respiratory Disease

|November 24, 2023

Summary

Pre-treatment lung function tests in small cell lung cancer (SCLC) can identify prognostic markers. Specifically, hyperinflation and reduced diffusing capacity are linked to poorer survival in SCLC patients.

Keywords:

SCLC body plethysmography diffusion capacity hyperinflation lung function

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

Related Experiment Videos

Last Updated: Jul 10, 2025

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

Area of Science:

Pulmonology
Oncology
Medical Diagnostics

Background:

Small cell lung cancer (SCLC) presents aggressive growth and poor prognosis, predominantly in heavy smokers.
The prognostic value of pre-therapeutic lung function testing in SCLC remains under-investigated.
This study aimed to identify prognostic markers within pre-therapeutic lung function parameters for SCLC patients.

Purpose of the Study:

To investigate the prognostic significance of pre-therapeutic lung function tests in patients diagnosed with SCLC.
To determine if specific lung function parameters correlate with survival outcomes in SCLC.
To explore the potential of lung function testing for risk stratification in SCLC.

Main Methods:

Retrospective analysis of 205 SCLC patients diagnosed between 2010 and 2018.
Extraction of pre-therapeutic spirometry, body plethysmography, and diffusing capacity measurements.
Statistical analysis using Mann-Whitney U-test, chi-square tests, Kaplan-Meier analysis, and COX-regression models.

Main Results:

Airway obstruction or COPD diagnosis did not correlate with SCLC survival.
Hyperinflation (increased residual volume, RV/TLC ratio) and reduced diffusing capacity were associated with significantly reduced survival (p < 0.001 and p = 0.007, respectively).
An emphysematous phenotype, characterized by hyperinflation and impaired gas exchange, correlated with the worst patient outcomes (p < 0.001).

Conclusions:

Body plethysmography and diffusing capacity measurements should be incorporated into the pre-therapeutic assessment of SCLC patients.
Reducing hyperinflation may improve outcomes for SCLC patients, suggesting the importance of managing comorbidities like COPD.
Further research into interventions like dual bronchodilation and respiratory physiotherapy to reduce hyperinflation in SCLC patients is warranted.